What is TBJ?
Since its inception in 1992, TBJ Incorporated has cultivated a reputation as a premier provider of specialized stainless steel equipment tailored for high-stakes environments. The company's product portfolio is engineered to meet the rigorous demands of hospital sterile processing departments, pathology and histology laboratories, hospital pharmacies, and research vivariums. Beyond its standard catalog, TBJ distinguishes itself through bespoke fabrication services, allowing for custom-engineered solutions that address unique client requirements. By maintaining a focus on durability and precision, the firm has solidified its position as an essential partner for institutions requiring reliable, sanitary, and high-performance laboratory infrastructure.
How much funding has TBJ raised?
TBJ has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in TBJ
PPP
Public-Private Partnership
What's next for TBJ?
With this recent capital deployment, TBJ is well-positioned to scale its manufacturing throughput and enhance its custom fabrication capabilities. The strategic focus will likely shift toward optimizing supply chain efficiencies and expanding its footprint within the hospital and research facility market. As the company leverages this financing, it is expected to prioritize technological integration in its production processes, ensuring that its stainless steel solutions continue to meet the evolving regulatory and operational standards of the global healthcare industry. This phase of growth marks a transition toward broader market penetration and sustained industrial leadership.
See full TBJ company page
